When Should You Start HCG for PCT? (TRT Q&As)
Timeline
A 30-year-old man asks whether HCG should begin while testosterone is still in his system or after waiting for the testosterone to clear. Dr. O’Connor explains the rationale behind using HCG during or after a cycle and discusses how HCG and Clomid may be used to help stimulate testicular and hormonal recovery.
Dr. O’Connor explains that telmisartan and valsartan are both ARBs but says he favors telmisartan because of its broader evidence and potential benefits beyond blood pressure control. He discusses when additional blood pressure medications may be considered and stresses individualized treatment based on response and overall health.
Dr. O’Connor cautions against adding 40 mg of Anavar daily on top of testosterone, particularly when cardiovascular risk markers are already unfavorable. He discusses how additional anabolic steroids can affect lipids, blood pressure, the heart, kidneys, and long-term health.
A 34-year-old man asks about Deca dosing based on the amount contained in one cc. Dr. O’Connor explains that the vial should list the concentration in milligrams per milliliter and also cautions that nandrolone can increase red blood cells and blood pressure and may cause sexual side effects.
Dr. O’Connor explains that cortisol fluctuates and warns against drawing conclusions from a single result. If morning cortisol remains abnormally high or there is concern about true cortisol excess or deficiency, he recommends evaluation by an endocrinologist to determine the underlying cause.
Video Summary
This mailbag discussion focuses on questions about injection frequency and whether splitting doses changes outcomes during testosterone therapy. It explains how dosing frequency influences peaks, troughs, and perceived stability. Injection schedules are framed as tools to reduce variability rather than optimize sensation.
A central portion discusses how individual response, labs, and symptom patterns guide decisions around dose splitting. The episode emphasizes avoiding unnecessary complexity without clear clinical reason. Contextual evaluation is highlighted.
The closing segment reinforces testosterone therapy as structured care requiring balance. Monitoring, proportional adjustments, and expectation alignment are emphasized. Hormone therapy is positioned as benefiting from simplicity when possible.
Drug Callouts
Condition Callouts
Key Takeaways
- Injection frequency influences stability.
- Dose splitting is not universally necessary.
- Complexity should have clinical justification.
- Monitoring guides schedule decisions.
- Simplicity often supports consistency.